These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Induction and postremission strategies in acute myeloid leukemia: state of the art and future directions. Rosenblat TL; Jurcic JG Hematol Oncol Clin North Am; 2011 Dec; 25(6):1189-213. PubMed ID: 22093583 [TBL] [Abstract][Full Text] [Related]
10. Stem cell transplantation as consolidation therapy for children in first-remission AML: a single-center report. Berger M; Ferrero I; Vassallo E; Gastaldo L; Carraro F; Biasin E; Madon E; Fagioli F Pediatr Hematol Oncol; 2005; 22(7):597-608. PubMed ID: 16166053 [TBL] [Abstract][Full Text] [Related]
11. Sequential regimen of chemotherapy, reduced-intensity conditioning for allogeneic stem-cell transplantation, and prophylactic donor lymphocyte transfusion in high-risk acute myeloid leukemia and myelodysplastic syndrome. Schmid C; Schleuning M; Ledderose G; Tischer J; Kolb HJ J Clin Oncol; 2005 Aug; 23(24):5675-87. PubMed ID: 16110027 [TBL] [Abstract][Full Text] [Related]
12. Is it appropriate to offer allogeneic hematopoietic stem cell transplantation to patients with primary refractory acute myeloid leukemia? Song KW; Lipton J Bone Marrow Transplant; 2005 Aug; 36(3):183-91. PubMed ID: 15937497 [TBL] [Abstract][Full Text] [Related]
13. [Hematopoietic stem cell transplantation for treatment of acute leukemia]. Harada M Gan To Kagaku Ryoho; 1999 Sep; 26(10):1387-95. PubMed ID: 10500524 [TBL] [Abstract][Full Text] [Related]
14. [Recent progress in the treatment of acute leukemia]. Kimura Y Gan To Kagaku Ryoho; 2003 Jul; 30(7):895-901. PubMed ID: 12894700 [TBL] [Abstract][Full Text] [Related]
15. Prognostic factors and therapeutic options for relapsed or refractory acute myeloid leukemia. Ferrara F; Palmieri S; Mele G Haematologica; 2004 Aug; 89(8):998-1008. PubMed ID: 15339685 [TBL] [Abstract][Full Text] [Related]
16. The role of cytotoxic therapy with hematopoietic stem cell transplantation in the therapy of acute myeloid leukemia in children: an evidence-based review. Oliansky DM; Rizzo JD; Aplan PD; Arceci RJ; Leone L; Ravindranath Y; Sanders JE; Smith FO; Wilmot F; McCarthy PL; Hahn T Biol Blood Marrow Transplant; 2007 Jan; 13(1):1-25. PubMed ID: 17222748 [TBL] [Abstract][Full Text] [Related]
17. Bone marrow transplantation for advanced acute leukemia: a pilot study of high-energy total body irradiation, cyclophosphamide and continuous infusion etoposide. Bostrom B; Weisdorf DJ; Kim T; Kersey JH; Ramsay NK Bone Marrow Transplant; 1990 Feb; 5(2):83-9. PubMed ID: 2107007 [TBL] [Abstract][Full Text] [Related]
18. [Dose-reduced conditioning before allogeneic stem cell transplantation: principles, clinical protocols and preliminary results]. Schmid C; Weisser M; Ledderose G; Stötzer O; Schleuning M; Kolb HJ Dtsch Med Wochenschr; 2002 Oct; 127(42):2186-92. PubMed ID: 12397547 [TBL] [Abstract][Full Text] [Related]
19. High-dose melphalan with or without stem cell support before myeloablative allo-SCT for remission induction in patients with advanced relapsed or refractory AML. O'Meara A; Pabst T; Heim D; Gerull S; Bucher C; Halter J; Arber C; Rovò A; Tichelli A; Gratwohl A; Stern M Bone Marrow Transplant; 2011 May; 46(5):636-40. PubMed ID: 20697364 [TBL] [Abstract][Full Text] [Related]
20. Toward optimization of postremission therapy for residual disease-positive patients with acute myeloid leukemia. Maurillo L; Buccisano F; Del Principe MI; Del Poeta G; Spagnoli A; Panetta P; Ammatuna E; Neri B; Ottaviani L; Sarlo C; Venditti D; Quaresima M; Cerretti R; Rizzo M; de Fabritiis P; Lo Coco F; Arcese W; Amadori S; Venditti A J Clin Oncol; 2008 Oct; 26(30):4944-51. PubMed ID: 18606980 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]